NPI: 1245703396 · BRONX, NY 10461 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/10/2019
| Authorized Official | DEBENEDICTIS, PASQUALE (MANAGER AND MEMBER) |
| NPI Enumeration Date | 01/10/2019 |
Other providers sharing the same authorized official: DEBENEDICTIS, PASQUALE
| Provider | City | State | Total Paid |
|---|---|---|---|
| PENINSULA CONTINUUM SERVICES LLC | FAR ROCKAWAY | NY | $3.38M |
| PROSPECT ACQUISITION III LLC | BROOKLYN | NY | $2.38M |
| MILLS POND DIALYSIS CENTER, LLC | WEST BABYLON | NY | $345K |
| MORNINGSIDE ACQUISITION I, LLC | BRONX | NY | $192K |
| SEA CREST ACQUISITION II, LLC | BROOKLYN | NY | $173K |
| NORWALK ACQUISITION I LLC | NORWALK | CT | $33K |
| STAMFORD ACQUISITION I, LLC | STAMFORD | CT | $423.03 |
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 11,854 | $177K |
| 2021 | 17,490 | $401K |
| 2022 | 6,531 | $242K |
| 2023 | 5,020 | $277K |
| 2024 | 2,477 | $157K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90935 | Hemodialysis procedure with single evaluation by a physician | 3,316 | 366 | $688K |
| 90937 | 32,067 | 635 | $458K | |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 227 | 25 | $43K |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 716 | 226 | $36K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 1,805 | 229 | $28K |
| A4657 | Syringe, with or without needle, each | 4,845 | 668 | $646.96 |
| J1756 | Injection, iron sucrose, 1 mg | 396 | 102 | $0.00 |